Pfizer Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
1. PFE's Q1 earnings expected to drop to 68 cents per share. 2. Projected quarterly revenue declines from $14.88 billion to $14.09 billion. 3. Collaboration with Guardant Health aims to enhance PFE's oncology portfolio. 4. Recent analyst ratings vary from Neutral to Buy, with lower price targets. 5. PFE shares rose 0.6% to $23.05 on Monday.